Kamilla Kjærgaard Munk

6PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Geomatic engineering not elsewhere classifiedGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 20, 2026
Dextran-based T-cell expansion nanoparticles for manufacturing CAR T cells with augmented efficacy.

Tao Zheng, Keerthana Ramanathan, Maria Ormhøj

|Jul 24, 2025
De novo-designed pMHC binders facilitate T cell-mediated cytotoxicity toward cancer cells.

Kristoffer Haurum Johansen, Darian Stephan Wolff, Beatrice Scapolo

|Oct 12, 2019
TCRpMHCmodels: Structural modelling of TCR-pMHC class I complexes.

Kamilla Kjærgaard Jensen, Vasileios Rantos, Emma Christine Jappe

|Jan 10, 2018
Improved methods for predicting peptide binding affinity to MHC class II molecules.

Kamilla Kjaergaard Jensen, Massimo Andreatta, Paolo Marcatili

Pageof 1